Abiopharma

Clinical trial NCT07214662 updates: 1. completion date: 2030-04-01 → 2030-06-01 2. primary completion date: 2030-04-01 → 2030-06-01

Clinical trial NCT07527832 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-27 3. primary completion date: 2026-05-31 → 2026-05-27 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05319314: enrollment: 30 → 155 participants.

Clinical trial NCT07256392: status: RECRUITING → ENROLLING_BY_INVITATION.

Clinical trial NCT04904549 updates: 1. status: COMPLETED → TERMINATED 2. start date: 2020-08-20 → 2021-05-26 3. enrollment: 23726 → 23670 participants

Clinical trial NCT07484022: start date: 2026-04-01 → 2026-06-01.

Clinical trial NCT07511387 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 40 → 50 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04164199 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-05-23 3. primary completion date: 2026-07-01 → 2026-05-23

Clinical trial NCT04338204 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2025-09-30 3. primary completion date: 2026-03-30 → 2025-09-30 4. enrollment: 120 → 102 participants 5. enrollment type: ESTIMATED → ACTUAL

Dormant shares - change in the number of shares